Zobrazeno 1 - 10
of 88
pro vyhledávání: '"J. Lacka"'
Publikováno v:
European Pharmaceutical Journal. 69:1-8
AIM The aim of the study was to evaluate cardiovascular risk in patients with diabetes mellitus type 2 according to gender. METHODS The monitoring was designed as a retrospective analysis of data obtained from the documentation of the diabetic outpat
Publikováno v:
European Pharmaceutical Journal; Jan2022, Vol. 69 Issue 1, p1-8, 8p
Autor:
E. Grey, Sálek T, A. Kunova, L. Drgona, J. Svec, P. Koren, J. Mardiak, J. Sufliarsky, E. Oravcova, E. Kukuckova, P. Pichna, J. Lacka, J. Trupl, M. Studena, Stanislav Spanik, Vladimir Krcmery
Publikováno v:
Journal of Medical Microbiology. 46:517-523
One hundred and twenty-three breakthrough bacteraemias (BB) were defined during a 5-year period in a National Cancer Centre, among 9986 admissions and a total of 979 bacteraemic episodes analysed. Of 123 bacteraemias in 103 patients, 77 were polymicr
Autor:
D. Sorkovska, L. Skodova, Vladimir Krcmery, E. Grey, J. Trupl, K. Stopkova, E. Oravcova, A Stankovská, P. Pichna, P. Koren, H. Hupkova, A. Kunova, I. Krupova, R. Botek, Stanislav Spanik, M. Mrazova, S. Grausova, J Svec, E. Kukuckova, J. Lacka, A. Krchnakova
Publikováno v:
International Journal of Antimicrobial Agents. 8:277-285
Fifty one episodes of bacteremia due to Enterobacter spp. appearing within 7 years among 12 301 admissions in a single cancer institution were studied for risk factors, clinical presentation and outcome. Fifteen episodes were due to Enterobacter aero
Autor:
K. Kralovicova, Stanislav Spanik, P. Koren, Vladimir Krcmery, E. Oravcova, E. Kukuckova, A. Kunova, E. Grey, J. Svec, J. Lacka, S. Grausova, P. Pichna, A. Demitrovicova, I. Krupova, J. Trupl
Publikováno v:
Acta Oncologica. 36:643-649
The resistance pattern of 2816 isolates from 17631 blood cultures and the etiology of isolates causing bacteremia and fungemia among 14591 admissions were investigated in an 80-bed single cancer institute during seven years (1990-1996) under the same
Autor:
M. Studena, Stanislav Spanik, J Silva, J Svec, L. Drgona, E. Grey, L. Sevcikova, J. Lacka, Vladimir Krcmery, E. Oravcova, E. Kukuckova
Publikováno v:
Infection. 24:319-323
Fifty cancer patients with funguria of10(5) CFU/ml, dysuria and leukocyturia were retrospectively analyzed for etiology, risk factors and outcome. In 72% of cases Candida albicans and in 28% non-albicans Candida spp. (Candida krusei, Candida tropical
Autor:
E. Oravcova, A. Kunova, I. Ilavska, Vladimir Krcmery, Stanislav Spanik, P. Koren, K. Stopkova, J. Trupl, P. Pichna, I. Krupova, M. Studena, J. Lacka, S. Grausova
Publikováno v:
International Journal of Antimicrobial Agents. 7:101-107
Two hundred and fourteen episodes of polymicrobial bacteremia in 182 cancer patients in a period of 6 years in a 360-bed National Cancer Institute were analyzed for etiology, risk factors and outcome. Variables were compared with 187 episodes of mono
Autor:
A. Kunová, J. Trupl, S. Špánik, L. Drgoňa, J. Šufliarsky, J. Lacka, V. Studená, E. Hlaváčová, M. Studená, E. Kukučková, T. Kollár, P. Pichňa, E. Oravcová, V. Krčméry, Jr.
Publikováno v:
Chemotherapy. 41:39-44
During the 5-year period 1989-1993, the incidence of Candida krusei, and other non-albicans Candida spp., was analyzed in a 60-bed cancer department. The frequency of C. krusei, before fluconazole was introduced into therapeutic protocols in 1990, wa
Autor:
Ignatius Tang, H. Nishiya, A. Vonkomerová, M. Aoki, H. Sugiyama, Walter H. Traub, Deh-Lin Cheng, V. Studená, Y. Tsutomi, Y. Kimura, T. Miyashita, Alan H. Lau, Y. Tokumura, E. Kukučková, Y. Ono, Mitsuhiko Akaboshi, V. Krčméry, Y. Kitano, E. Capocasale, Oliver Gaillot, Kenichi Kawai, John F. Fitzloff, K. Akahane, Mitsuyuki Abe, L. Hel’pianska, Shyamala Devi, S. Subramaniam, J. Šufliarsky, Wen-Kuei Huang, M.P. Mazzoni, Atef M. Shibl, Koji Ono, Birgit Leonhard, Rashmi Jain, Raymond P. Smith, Yung-Ching Liu, O. Kunii, E. Goldstein, I. Ohyatsu, T. Šálek, M. Studená, William J. Ritz, Masao Takagaki, P. Pichňa, S. Tondo, M. Jagadeesan, J. Lacka, Aldona L. Baltch, E. Hlaváčová, Shin-ichiro Masunaga, T. Kollár, H. Miyashita, Keizo Akuta, G. D’Errico, J. Trupl
Publikováno v:
Chemotherapy. 40:I-VI
Autor:
M. Studena, E. Kukuckova, A. Vonkomerová, Vladimir Krcmery, L. Helpianska, T. Kollár, J. Sufliarsky, J. Lacka, V. Studena, E Hlavácová, J. Trupl, P. Pichňa, Sálek T
Publikováno v:
Chemotherapy. 40:431-434
In a comparative randomized trial, teicoplanin 5 mg/kg plus either netilmicin 5 mg/kg or pefloxacine 10 mg/kg was administered in a once daily empiric therapy to 40 cancer patients with fever and neut